Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NHWK | Stock Option (right to buy) | Other | $0 | -232K | -100% | $0.00* | 0 | Dec 30, 2021 | Common Stock | 232K | $4.07 | Direct | F1 |
transaction | NHWK | Stock Option (right to buy) | Award | $0 | +232K | $0.00 | 232K | Dec 30, 2021 | Common Stock | 232K | $4.07 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | On December 28, 2021, the board of directors of Heat Biologics, Inc. (the "Company") rescinded and cancelled stock option awards previously made to Mr. Wolf on December 13, 2021 covering 231,987 shares under the Company's 2018 Stock Incentive Plan (the "Plan") and granted new stock options under the Plan, on substantially similar terms to the rescinded stock options, which new stock options are subject to forfeiture in the event an amendment to increase the number of shares of common stock available for grant under the Plan is not adopted by the Company's stockholders. |
F2 | The stock options to purchase 231,987 shares of Common Stock vest on the two-year anniversary of the date of grant, subject to the reporting person's continued service to the Company and is subject to forfeiture under certain circumstances. |